1. Home
  2. VOXR vs ASMB Comparison

VOXR vs ASMB Comparison

Compare VOXR & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VOXR
  • ASMB
  • Stock Information
  • Founded
  • VOXR 2014
  • ASMB 2005
  • Country
  • VOXR United States
  • ASMB United States
  • Employees
  • VOXR N/A
  • ASMB N/A
  • Industry
  • VOXR Precious Metals
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VOXR Basic Materials
  • ASMB Health Care
  • Exchange
  • VOXR Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • VOXR 168.0M
  • ASMB 141.8M
  • IPO Year
  • VOXR N/A
  • ASMB 2010
  • Fundamental
  • Price
  • VOXR $3.18
  • ASMB $18.51
  • Analyst Decision
  • VOXR
  • ASMB Strong Buy
  • Analyst Count
  • VOXR 0
  • ASMB 3
  • Target Price
  • VOXR N/A
  • ASMB $33.00
  • AVG Volume (30 Days)
  • VOXR 826.5K
  • ASMB 43.3K
  • Earning Date
  • VOXR 08-06-2025
  • ASMB 08-07-2025
  • Dividend Yield
  • VOXR 1.54%
  • ASMB N/A
  • EPS Growth
  • VOXR N/A
  • ASMB N/A
  • EPS
  • VOXR N/A
  • ASMB N/A
  • Revenue
  • VOXR $10,845,445.00
  • ASMB $32,154,000.00
  • Revenue This Year
  • VOXR $16.51
  • ASMB $0.04
  • Revenue Next Year
  • VOXR $4.60
  • ASMB N/A
  • P/E Ratio
  • VOXR N/A
  • ASMB N/A
  • Revenue Growth
  • VOXR N/A
  • ASMB 148.33
  • 52 Week Low
  • VOXR $2.21
  • ASMB $7.75
  • 52 Week High
  • VOXR $3.79
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • VOXR 43.45
  • ASMB 63.34
  • Support Level
  • VOXR $3.04
  • ASMB $18.13
  • Resistance Level
  • VOXR $3.39
  • ASMB $19.11
  • Average True Range (ATR)
  • VOXR 0.16
  • ASMB 0.81
  • MACD
  • VOXR -0.01
  • ASMB -0.06
  • Stochastic Oscillator
  • VOXR 26.53
  • ASMB 77.83

About VOXR Vox Royalty Corp.

Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: